VQW-765
Asset
Activates alpha-7 nicotinic acetylcholine receptors as a partial agonist.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Social anxiety disorder
Phase 3, endpoints.news, Oct 15, 2026
In the full profile
- Owner and partners1
- Competitors7
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.